Nvidia hits record high as analyst predicts AI 'Golden Wave'
By Noel Randewich
Nvidia
's stock hit a record high on Wednesday, and the chipmaker reclaimed the crown as the world's most valuable company after an analyst said the chipmaker was set to ride a "Golden Wave" of
artificial intelligence
.
Shares of the Santa Clara, California-based company rose over 4% to a record high of $154.10. The rise sent Nvidia's
stock market
value to $3.76 trillion, overtaking Microsoft , which was last valued at $3.65 trillion following a 0.2% increase in its stock.
Fueling Nvidia's latest rally, Loop Capital lifted its price target for the designer of high-end AI processors to $250 from $175, while maintaining its "buy" rating.
"Our work suggests we are entering the next 'Golden Wave' of Gen AI adoption and NVDA is at the front-end of another material leg of stronger than anticipated demand," Loop Capital analyst Ananda Baruah wrote in a client note.
Nvidia's latest gains reflect the U.S. stock market's return to the "AI trade" that fueled massive gains in chip stocks and related technology companies in recent years on optimism about the emerging technology.
Nvidia recently traded at about 30 times analysts' expected earnings for the next 12 months, below its average of about 40 over the past five years, according to LSEG data. That relatively modest price-to-earnings valuation reflects steadily increasing earnings estimates that have outpaced Nvidia's sizable stock gains.
Nvidia, Microsoft and Apple have traded places several times as the world's most valuable company over the past year, with Microsoft leading recently after overtaking Nvidia in early June.
Apple's stock rose 0.4% on Wednesday, putting its value at $3.0 trillion.
Nvidia has now rebounded over 60% from its closing low on April 4, when Wall Street was reeling from President Donald Trump's global tariff announcements. U.S. stocks, including Nvidia, have recovered on expectations the White House will reach trade deals to soften the tariffs.
The S&P 500 technology sector index was last up 0.9% at an all-time high. It has now gained almost 6% in 2025.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
22 minutes ago
- Business Standard
Crizac to launch ₹860 cr IPO on July 2 with reduced OFS component
Student recruitment solution provider Crizac on Thursday said its Rs 860-crore initial public offering (IPO) will hit the capital markets for subscription on July 2. The public issue will conclude on July 4, and the bidding for anchor investors will open for a day on July 1, the company said in a statement. However, the company did not disclose the details of the price band. The IPO is entirely an offer for sale (OFS) of equity shares worth Rs 860 crore by promoters Pinky Agarwal and Manish Agarwal with no fresh issue component, according to the red herring prospectus (RHP) filed on Wednesday. The OFS consists of the sale of equity shares worth Rs 723 crore by Pinky Agarwal and Rs 137 crore by Manish. Since the issue is an OFS, Crizac will not receive any proceeds from the IPO. The company, which had proposed to raise Rs 1,000 crore in November last year, has now trimmed the issue size to Rs 860 crore. It did not provide any specific reason for the downward revision in offer size. Crizac initially filed its preliminary IPO papers with Sebi in March 2024. The regulator had returned the documents in July. Thereafter, the company refiled the papers in November, which were approved by the regulator in March this year. The Kolkata-based firm is a B2B education platform for agents and global institutions, which offers international student recruitment solutions to global institutions of higher education in the UK, Ireland, Canada, Australia and New Zealand. Over the last three years, Crizac facilitated enrolment applications from over 75 countries through its registered agents on its technology platform. It processed more than 7.11 lakh student applications and collaborated with over 173 global institutions of higher education. The company reported a revenue from operations of Rs 849.49 crore and a profit after tax of Rs 152.93 crore in the full financial year 2025. The company's shares will be listed on the BSE and NSE. Equirus Capital and Anand Rathi Advisors are the book-running lead managers, while MUFG Intime India is the registrar for the IPO. (Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Mint
27 minutes ago
- Mint
Should you buy OPD insurance? Get the complete lowdown to help you decide.
Imagine this: you have some health issues and visit a doctor. She prescribes you medicines and a couple of diagnostic tests. You pay a good amount of money for the doctor's consultation, medicines and tests, and wonder whether your health insurance policy will cover it. Well, here's the bad news: most health insurance policies do not cover outpatient department (OPD) expenses. According to a report by India Insurtech Association, India's OPD spending amounted to a massive $37.7 billion in FY24, of which retail OPD insurance accounted for less than 0.1%. Noting this gap, insurers have of late started to offer OPD coverage and healthcare startups have also entered the space, providing OPD subscription plans directly to customers or via employers. Here's a lowdown of what all is available. OPD plans from insurers India's OPD market is highly fragmented, so providing coverage is difficult. The high chances of billing fraud can't be ignored, so insurers prefer to offer OPD coverage on a cashless basis, allowing you to only visit their network partners for doctor consultations and diagnostics. Some insurers may agree to reimburse the cost incurred at non-network facilities as well. Among popular plans, as shared by ICICI Lombard's Elevate comes with an OPD+ rider. The premium varies by age. A 35-year-old male must pay ₹4,980 annually for ₹10,000 OPD coverage in a year. The plan only works on a cashless model and has no sub-limits on procedures such as dental and vision. Bajaj Allianz's Health Prime and Niva Bupa's Acute-Best Care offer both cashless facilities and reimbursements. The former has a premium of 2,062 for ₹15,000 coverage while latter costs ₹4,801 for ₹10,000 coverage for a 35-year old individual. Niva Bupa's Well Consult-OPD puts a co-payment of 20% if a policyholder files for reimbursement. Star Health Insurance has a standalone OPD insurance policy that allows cashless and reimbursement only for accident-related emergencies. A 35-year old individual will pay ₹4,802 for ₹25,000 coverage. This plan has a waiting period of 1-3 years for OPD expenses of pre-existing diseases. "Traditionally the OPD plans had sub-limits on doctor consultation, diagnostic tests or pharmacy bills. For example, the OPD sum insured could very well be ₹20,000 but pharmacy bills having a sub-limit of ₹5,000. But insurers are increasingly launching plans with no sub-limits for customers to utilise the OPD benefit in the way they want," said Siddharth Singhal, business head - health insurance, Direct-to-consumer plans Lucknow-based Geeta Srivastava (66) heard about healthcare startup LivLong's OPD plan Eldercare. "The plan costs me ₹12,000 a year. OPD benefits such as medicines and lab tests are restricted to ₹3,000 a year, but there are other useful benefits such as full-body check-up (83 parameters), unlimited consultation with doctors and nutritionists, six consultations a year with specialists and two free ambulance services. Another benefit is having a healthcare manager at my disposal who checks up on me every now and then and helps me with what I require," Srivastava said. Data from LivLong showed they have three plans, priced at ₹5500, ₹6,000 and ₹11,599. "These plans have a perceived value of ₹15,000, ₹16,000 and ₹28,800, respectively," said Gaurav Dubey, founder & CEO, LivLong 365. To be sure, there is no underlying sum insured in LivLong OPD plans. They offer up to 50% discounts on OPD benefits such as consultations, lab tests, diagnostics and medicines, which translate into perceived savings. Healthcare provider Even Health offers OPD insurance in partnership with Magma General Insurance. However, you can't buy standalone OPD cover from them. You need to buy IPD cover (sum insured ranges from ₹3 lakh to ₹1 crore) in which OPD cover of ₹10 lakh will be inlcuded if you pay extra over the premium. People aged 0-35 years can buy it for around 4,500 a year, 36-49 years for ₹10,000 a year, and over 50 for ₹19,000 a year, excluding the premium for IPD coverage. "Our OPD plan works everywhere in the country on a cashless basis. We have partners in every pin code from Lakshadweep to Leh. We not only cover doctor's consultations but also diagnostic (radiology, pathology) and medicines. We offer reimbursement, too, but with 50% co-pay," said Mayank Banerjee, Co founder, Coverage from your employer Companies such as Onsurity and Plum, or for that matter even Even Health and LivLong, curate OPD coverage in partnership with employers to offer it to employees. Noida-based Anmol Bhushan (28) works with a financial services firm as an actuarial consultant. His employer offers OPD benefits as part of its wellness services. He pays ₹11,000 per year to insure himself and his parents for a maximum benefit of ₹21,000. "The plan has a co-payment of 10% for me and 20% for my parents. Each year I manage to avail of at least ₹18,000 benefit," said Bhushan. Data from Onsurity shows their wellness OPD plans cost a minimum of ₹145 more per member per month and can go up to ₹4,500 or more based on the features. "Pricing retail OPD plans at a low cost is difficult because the utilisation will be high in those plans. We offer it to them via employers so that the utilisation is comparatively lower and we can keep the pricing viable," said Suman Pal, chief claims officer at Onsurity. Can't argue with free Some employers offer the benefit to employees for free. Mumbai-based Dipen Chheda (50) for example, used it while he was working with his previous employer. "The challenge in that plan was the limited number of associated partners. If I have to take doctor consultation and no network doctor is available nearby, it does not make sense for me to go far. Similarly, nearby chemists also offer discounts on medicines. Sometimes those are better than what OPD cover offers," he said. For Bengaluru-based Shobhit Katikia (27), the experience has been great. "We get a flat coverage of ₹20,000 per year from our employer. I don't have to pay for it. It covers me and my parents. I availed the claim twice in the past two years – for dental treatment that included the procedure and medicines in the first year, and for new glasses in the second year. The cost of the eye check-up, frame and lens was all covered," he said. In his case, he could choose any doctor or pharmacy and file for reimbursement. "The claims were approved in 24 hours," he said. Should you buy an OPD plan? Well, it depends on the cashless network the platform provides, and the sub-limits. "We have noticed that doctors empaneled with different such platforms may just have an MBBS degree and not really be specialists. The way the OPD market works is people may want to visit specialists and diagnostic centres of their choice. We are in the process of launching retail OPD cover, which will address these issues," said Saurabh Vijayvergia. founder & CEO, CoverSure. Mint's take India's OPD insurance market is at a nascent stage. While employer-linked OPD cover offers decent benefits, there are very few direct-to-customer options from healthcare startups. There is greater variety in policies offered by insurers. Whichever option you choose, sub-limits on various benefits make such plans restrictive. You could considering buying it to giving it a try if you can afford it.
Time of India
31 minutes ago
- Time of India
Microsoft sued by authors for allegedly using pirated books to train AI model
A group of prominent authors, including Pulitzer Prize winner Kai Bird and New Yorker writer Jia Tolentino, has filed a lawsuit against Microsoft, accusing the tech giant of illegally using pirated versions of their books to train its AI model known as 'Megatron. ' Filed in a New York federal court on June 25, the suit claims that Microsoft copied nearly 200,000 copyrighted works without permission to develop AI systems that mimic the authors' unique writing styles, themes, and voices. This marks another major legal challenge in the growing debate over AI training and copyright law. Authors accuse Microsoft of copyright infringement The plaintiffs allege that Microsoft used a massive dataset of pirated digital books to train Megatron, a generative AI model designed to produce human-like text. According to the complaint, the AI's ability to replicate the tone, syntax, and narrative patterns of copyrighted works demonstrates a clear violation of intellectual property rights. The authors argue that their creative output was exploited to build a product that competes with them in the marketplace, without their consent or compensation. Lawsuit demands damages and a court injunction The writers are seeking statutory damages of up to $150,000 per infringed work, along with a court order to block Microsoft from continuing its alleged unauthorised use of their materials. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Buy Brass Idols - Handmade Brass Statues for Home & Gifting Luxeartisanship Buy Now Undo While the exact number of infringed titles remains unclear, the plaintiffs claim that thousands of authors' works may have been used without licence or attribution. The case could set a precedent for how courts handle AI training involving copyrighted content. Legal backdrop: A turning point in AI copyright battles This lawsuit comes just one day after a California judge ruled that AI firm Anthropic may have made 'fair use' of copyrighted material in training but could still be liable for using pirated versions of books. It was the first US decision to address the legality of using copyrighted texts in generative AI development. The Microsoft case adds further momentum to a wave of lawsuits from writers, artists, and media outlets challenging how their work is used by tech companies. Microsoft yet to respond publicly According to Reuters, Microsoft has not issued an official response to the allegations. A spokesperson for the company declined to comment when contacted by reporters. Meanwhile, legal observers say this case will be closely watched for its implications on the future of AI development and intellectual property rights. A growing challenge for the AI industry Tech firms including Meta, OpenAI, and Anthropic have all faced similar legal scrutiny in recent time. The central argument from the companies is that using public data for AI training qualifies as 'fair use' under US copyright law. However, rights holders argue that this approach undermines creators' control and devalues their work. As AI models become increasingly sophisticated, courts should define clearer boundaries around what constitutes ethical and legal data usage.
